Spero Therapeutics Inc (SPRO)
NASDAQ:SPRO
Holding SPRO?
Track your performance easily

Spero Therapeutics (SPRO) Financial Statements

499 Followers

Spero Therapeutics Financial Overview

Spero Therapeutics's market cap is currently ―. The company's EPS TTM is $0.335; its P/E ratio is 3.97; Spero Therapeutics is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-0.50. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 10.20M$ 9.27M$ 71.83M$ 25.47M$ 2.72M
Gross Profit$ 10.20M$ 9.27M$ 73.52M$ 25.47M$ 2.72M
EBIT$ -17.86M$ -21.80M$ 51.58M$ -994.00K$ -11.91M
EBITDA$ -17.86M$ -21.80M$ 51.62M$ -886.00K$ -11.81M
Net Income Common Stockholders$ -17.86M$ -12.67M$ 51.19M$ -3.19M$ -11.91M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 63.53M$ 82.27M$ 76.33M$ 93.83M$ 77.69M
Total Assets$ 149.88M$ 167.70M$ 182.39M$ 107.10M$ 98.89M
Total Debt$ 4.96M$ 5.28M$ 5.63M$ 5.89M$ 6.18M
Net Debt$ -58.56M$ -76.99M$ -70.70M$ -87.93M$ -71.51M
Total Liabilities$ 69.38M$ 71.45M$ 75.50M$ 53.40M$ 44.10M
Stockholders Equity$ 80.50M$ 96.25M$ 106.89M$ 53.70M$ 54.74M
Cash Flow-
Free Cash Flow$ -18.74M$ 5.94M$ -17.49M$ 15.91M$ -18.56M
Operating Cash Flow$ -18.74M$ 5.94M$ -17.49M$ 15.91M$ -18.56M
Investing Cash Flow-----
Financing Cash Flow--$ 1.00K$ 220.00K-
Currency in USD

Spero Therapeutics Earnings and Revenue History

Spero Therapeutics Debt to Assets

Spero Therapeutics Cash Flow

Spero Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis